Alpha-glucosidase inhibitor decreases the risk of colorectal adenoma in the aged with Type 2 diabetes
Abstract The rapidly aging population is fueling a surge in diabetes, especially Type 2, which heightens colorectal cancer (CRC) risk. Colorectal adenoma, a precursor, compounds this trend. Although alpha-glucosidase inhibitors are effective hypoglycemic drugs working in the GI tract, the link betwe...
Saved in:
Main Authors: | Dingchao Xia, Lanling Jin, Binfeng Wang, Yi Jin, Qun Zheng, Jie Xu, Senzhong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-84294-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of thymol-fused chalcones as new competitive \(\alpha\)-glucosidase inhibitors: Design, synthesis, biological evaluation, and molecular modeling studies
by: Ade Danova, et al.
Published: (2024-12-01) -
New semisynthetic α-glucosidase inhibitor from a doubly-chemically engineered extract
by: María I. Osella, et al.
Published: (2025-01-01) -
Stereospecific α-glucosidase inhibition, kinetics, and molecular docking studies on isolated diastereomeric alkaloids from Uncaria longiflora
by: Nurul Aina Suzlin Sulaiman, et al.
Published: (2025-01-01) -
Bioactive constituents from the leaves of Quercus phillyraeoides A. Gray for α-glucosidase inhibitor activity with concurrent antioxidant activity
by: Anastasia Wheni Indrianingsih, et al.
Published: (2016-06-01) -
Clinicopathological Characteristics of Middle-Aged and Elderly Patients with Colorectal Polyps and Risk Factors of Adenomatous Polyps
by: Rui CHENG, et al.
Published: (2025-01-01)